BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 8838228)

  • 1. Molecular diagnosis of cystic fibrosis.
    Kant JA; Mifflin TE; McGlennen R; Rice E; Naylor E; Cooper DL
    Clin Lab Med; 1995 Dec; 15(4):877-98. PubMed ID: 8838228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of cystic fibrosis.
    Shrimpton AE
    Expert Rev Mol Diagn; 2002 May; 2(3):240-56. PubMed ID: 12050863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.
    Feriotto G; Ferlini A; Ravani A; Calzolari E; Mischiati C; Bianchi N; Gambari R
    Hum Mutat; 2001; 18(1):70-81. PubMed ID: 11438995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A molecular genetic analysis of the mutations in the exons of the CFTR gene in cystic fibrosis patients in Ukraine].
    Livshyts' LA
    Tsitol Genet; 2000; 34(4):6-9. PubMed ID: 11033850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The type and frequency of mutations in CFTR gene occurrence in patients with cystic fibrosis in Poland--implication of results obtained from genetic counseling and diagnostic screening].
    Bal J; Maciejko D; Mazurczak T
    Pediatr Pol; 1995 Aug; 70(8):627-32. PubMed ID: 8668362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
    Romey MC
    Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
    Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
    Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of CFTR gene rearrangements impacts on genetic counselling in cystic fibrosis.
    Niel F; Martin J; Dastot-Le Moal F; Costes B; Boissier B; Delattre V; Goossens M; Girodon E
    J Med Genet; 2004 Nov; 41(11):e118. PubMed ID: 15520400
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved detection of CFTR mutations in Southern California Hispanic CF patients.
    Wong LJ; Wang J; Zhang YH; Hsu E; Heim RA; Bowman CM; Woo MS
    Hum Mutat; 2001 Oct; 18(4):296-307. PubMed ID: 11668613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative genetic neonatal screening for cystic fibrosis caused by compound heterozygosity for two large CFTR rearrangements.
    Girardet A; Guittard C; Altieri JP; Templin C; Stremler N; Beroud C; des Georges M; Claustres M
    Clin Genet; 2007 Oct; 72(4):374-7. PubMed ID: 17850636
    [No Abstract]   [Full Text] [Related]  

  • 12. A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations.
    Costes B; Fanen P; Goossens M; Ghanem N
    Hum Mutat; 1993; 2(3):185-91. PubMed ID: 7689902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cystic fibrosis: the CFTR gene, its mutations, the genetic counseling].
    Goossens M; Ghanem N; Girodon E; Costes B; Fanen P
    Rev Pneumol Clin; 1995; 51(3):130-6. PubMed ID: 7569574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large deletions in the CFTR gene: clinics and genetics in Swiss patients with CF.
    Schneider M; Hirt C; Casaulta C; Barben J; Spinas R; Bühlmann U; Spalinger J; Schwizer B; Chevalier-Porst F; Gallati S
    Clin Genet; 2007 Jul; 72(1):30-8. PubMed ID: 17594397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular basis of phenotype heterogeneity in cystic fibrosis].
    Bienvenu T
    Ann Biol Clin (Paris); 1997; 55(2):113-21. PubMed ID: 9180964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for cystic fibrosis.
    Wallace J; Stein Q
    S D Med; 2006 Oct; 59(10):429-31. PubMed ID: 17124920
    [No Abstract]   [Full Text] [Related]  

  • 18. Prenatal screening for cystic fibrosis: past, present and future.
    Richards CS; Grody WW
    Expert Rev Mol Diagn; 2004 Jan; 4(1):49-62. PubMed ID: 14711349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
    Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
    Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.